Tuesday | Nov 05 2024 |
Indian Immunologicals Limited (IIL), has signed a Memorandum of Agreement (MoA) with the Indian Council of Medical Research (ICMR) for the clinical development of India’s first codon de-optimised live attenuated Zika vaccine.
Subscribe to our newsletter to get updates on our latest news
